| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
257-260 |
CHEBI_33697 |
denotes |
RNA |
| T1 |
285-291 |
HP_0012828 |
denotes |
severe |
| T2 |
292-297 |
HP_0011009 |
denotes |
acute |
| T17 |
298-317 |
HP_0002795 |
denotes |
respiratory disease |
| T16 |
298-317 |
DOID_1579 |
denotes |
respiratory disease |
| T18 |
327-335 |
HP_0033141 |
denotes |
COVID-19 |
| T4 |
327-335 |
DOID_0080600 |
denotes |
COVID-19 |
| T19 |
346-354 |
HP_0033141 |
denotes |
COVID-19 |
| T5 |
346-354 |
DOID_0080600 |
denotes |
COVID-19 |
| T21 |
374-391 |
HP_0002795 |
denotes |
pulmonary disease |
| T20 |
374-391 |
DOID_850 |
denotes |
pulmonary disease |
| T7 |
412-418 |
HP_0012828 |
denotes |
severe |
| T22 |
419-440 |
HP_0001626 |
denotes |
cardiovascular damage |
| T23 |
507-524 |
HP_0001637 |
denotes |
myocardial injury |
| T24 |
614-622 |
HP_0033141 |
denotes |
COVID-19 |
| T9 |
614-622 |
DOID_0080600 |
denotes |
COVID-19 |
| T27 |
834-842 |
HP_0033141 |
denotes |
COVID-19 |
| T10 |
834-842 |
DOID_0080600 |
denotes |
COVID-19 |
| T25 |
1319-1338 |
CHEBI_80233 |
denotes |
natriuretic peptide |
| T11 |
1344-1352 |
CHEBI_16919 |
denotes |
creatine |
| T26 |
1453-1473 |
HP_0033141 |
denotes |
SARS-CoV-2 infection |
| T12 |
1453-1473 |
DOID_0080600 |
denotes |
SARS-CoV-2 infection |
| T28 |
1597-1605 |
HP_0033141 |
denotes |
COVID-19 |
| T13 |
1597-1605 |
DOID_0080600 |
denotes |
COVID-19 |
| T14 |
1621-1626 |
HP_0011009 |
denotes |
acute |
| T30 |
1627-1656 |
HP_0030872 |
denotes |
cardiovascular decompensation |
| T29 |
1689-1709 |
HP_0033141 |
denotes |
SARS-CoV-2 infection |
| T15 |
1689-1709 |
DOID_0080600 |
denotes |
SARS-CoV-2 infection |
| R11 |
T9 |
T0 |
effect |
COVID-19,RNA |
| R14 |
T12 |
T11 |
effect |
SARS-CoV-2 infection,creatine |
| R16 |
T13 |
T11 |
no_relation |
COVID-19,creatine |
| R18 |
T15 |
T11 |
effect |
SARS-CoV-2 infection,creatine |
| R19 |
T2 |
T17 |
effect |
acute,respiratory disease |
| R20 |
T1 |
T17 |
effect |
severe,respiratory disease |
| R21 |
T1 |
T16 |
effect |
severe,respiratory disease |
| R22 |
T2 |
T16 |
effect |
acute,respiratory disease |
| R23 |
T7 |
T22 |
effect |
severe,cardiovascular damage |
| R24 |
T19 |
T22 |
effect |
COVID-19,cardiovascular damage |
| R25 |
T5 |
T22 |
effect |
COVID-19,cardiovascular damage |
| R26 |
T18 |
T22 |
effect |
COVID-19,cardiovascular damage |
| R27 |
T4 |
T22 |
effect |
COVID-19,cardiovascular damage |
| R28 |
T24 |
T23 |
effect |
COVID-19,myocardial injury |
| R29 |
T9 |
T23 |
effect |
COVID-19,myocardial injury |
| R30 |
T26 |
T11 |
effect |
SARS-CoV-2 infection,creatine |
| R31 |
T29 |
T11 |
effect |
SARS-CoV-2 infection,creatine |
| R32 |
T28 |
T11 |
effect |
COVID-19,creatine |
| R33 |
T13 |
T25 |
effect |
COVID-19,natriuretic peptide |
| R34 |
T28 |
T25 |
effect |
COVID-19,natriuretic peptide |
| R35 |
T12 |
T25 |
effect |
SARS-CoV-2 infection,natriuretic peptide |
| R36 |
T26 |
T15 |
effect |
SARS-CoV-2 infection,SARS-CoV-2 infection |
| R37 |
T29 |
T25 |
effect |
SARS-CoV-2 infection,natriuretic peptide |
| R38 |
T28 |
T30 |
effect |
COVID-19,cardiovascular decompensation |
| R39 |
T13 |
T30 |
effect |
COVID-19,cardiovascular decompensation |
| R40 |
T14 |
T30 |
effect |
acute,cardiovascular decompensation |
| R5 |
T4 |
T0 |
no_relation |
COVID-19,RNA |
| R7 |
T5 |
T0 |
no_relation |
COVID-19,RNA |
